Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community‐dwelling older patients acutely admitted to hospital? A Norwegian registry‐based study. Issue 6 (10th January 2023)
- Record Type:
- Journal Article
- Title:
- Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community‐dwelling older patients acutely admitted to hospital? A Norwegian registry‐based study. Issue 6 (10th January 2023)
- Main Title:
- Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community‐dwelling older patients acutely admitted to hospital? A Norwegian registry‐based study
- Authors:
- Havnes, Kjerstin
Svendsen, Kristian
Johansen, Jeanette Schultz
Granas, Anne Gerd
Garcia, Beate Hennie
Halvorsen, Kjell H. - Abstract:
- Abstract: Purpose: Investigate the association between anticholinergic (AC) and sedative (SED) drug burden before hospitalization and postdischarge institutionalization (PDI) in community‐dwelling older patients acutely admitted to hospital. Methods: A cross‐sectional study using data from the Norwegian Patient Registry and the Norwegian Prescription Database. We studied acutely hospitalized community‐dwelling patients ≥70 years during 2013 ( N = 86 509). Patients acutely admitted to geriatric wards underwent subgroup analyses ( n = 1715). We calculated drug burden by the Drug Burden Index (DBI), use of AC/SED drugs, and the number of AC/SED drugs. Piecewise linearity of DBI versus PDI and a knot point (DBI = 2.45) was identified. Statistical analyses included an adjusted multivariable logistic regression model. Results: In the total population, 45.4% were exposed to at least one AC/SED drug, compared to 52.5% in the geriatric subgroup. AC/SED drugs were significantly associated with PDI. The DBI with odds ratios (ORs) of 1.11 (95% CI 1.07–1.15) for DBI < 2.45 and 1.08 (95% CI 1.04–1.13) for DBI ≥ 2.45. The number of AC/SED drugs with OR of 1.07 (95% CI 1.05–1.09). The AC component of DBI with OR 1.23 and the number of AC drugs with OR 1.13. In the subgroup, ORs were closer to 1 for AC drugs. Conclusions: The use of AC/SED drugs was highly prevalent in older patients before acute hospital admissions, and significantly associated with PDI. The number, or just using AC/SEDAbstract: Purpose: Investigate the association between anticholinergic (AC) and sedative (SED) drug burden before hospitalization and postdischarge institutionalization (PDI) in community‐dwelling older patients acutely admitted to hospital. Methods: A cross‐sectional study using data from the Norwegian Patient Registry and the Norwegian Prescription Database. We studied acutely hospitalized community‐dwelling patients ≥70 years during 2013 ( N = 86 509). Patients acutely admitted to geriatric wards underwent subgroup analyses ( n = 1715). We calculated drug burden by the Drug Burden Index (DBI), use of AC/SED drugs, and the number of AC/SED drugs. Piecewise linearity of DBI versus PDI and a knot point (DBI = 2.45) was identified. Statistical analyses included an adjusted multivariable logistic regression model. Results: In the total population, 45.4% were exposed to at least one AC/SED drug, compared to 52.5% in the geriatric subgroup. AC/SED drugs were significantly associated with PDI. The DBI with odds ratios (ORs) of 1.11 (95% CI 1.07–1.15) for DBI < 2.45 and 1.08 (95% CI 1.04–1.13) for DBI ≥ 2.45. The number of AC/SED drugs with OR of 1.07 (95% CI 1.05–1.09). The AC component of DBI with OR 1.23 and the number of AC drugs with OR 1.13. In the subgroup, ORs were closer to 1 for AC drugs. Conclusions: The use of AC/SED drugs was highly prevalent in older patients before acute hospital admissions, and significantly associated with PDI. The number, or just using AC/SED drugs, gave similar associations with PDI compared to applying the DBI. Using AC drugs showed higher sensitivity, indicating that to reduce the risk of PDI, a clinical approach could be to reduce the number of AC drugs. … (more)
- Is Part Of:
- Pharmacoepidemiology and drug safety. Volume 32:Issue 6(2023)
- Journal:
- Pharmacoepidemiology and drug safety
- Issue:
- Volume 32:Issue 6(2023)
- Issue Display:
- Volume 32, Issue 6 (2023)
- Year:
- 2023
- Volume:
- 32
- Issue:
- 6
- Issue Sort Value:
- 2023-0032-0006-0000
- Page Start:
- 607
- Page End:
- 616
- Publication Date:
- 2023-01-10
- Subjects:
- anticholinergics -- drug burden index -- hospitalization -- institutionalization -- National Health Registries -- older patients -- sedatives
Pharmacoepidemiology -- Periodicals
Chemotherapy -- Periodicals
Epidemiology -- Periodicals
615.705 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/pds.5590 ↗
- Languages:
- English
- ISSNs:
- 1053-8569
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6446.248000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 27093.xml